Tumor Biology

, Volume 35, Issue 3, pp 2297–2301 | Cite as

A randomized clinical trial of nerve block to manage end-stage pancreatic cancerous pain

  • Ling Gao
  • Yi-jin Yang
  • Hai-yan Xu
  • Jin Zhou
  • Han Hong
  • Yun-liang Wang
  • De-chun Li
Research Article
First Online:
Received:
Accepted:

Abstract

Pain control is the most difficult puzzle in patients with terminal pancreatic cancerous pain. Many methods in clinical practice fail in 20 ~ 50 % of patients. The present study aims to explore the effect of nerve block on patients with end-stage pancreatic cancerous pain. In this study, 100 subjects with end-stage pancreatic cancerous pain were enrolled and randomly assigned into two groups: 68 in nerve block group (N) and 32 in sham group (S). One group was treated with nerve block and the other group with sham procedure as controls. The pain score (by visual analog scale (VAS)), pain duration, reduction of other analgesic medications, and quality of life (with questionnaire QLQ) were evaluated before and 3 months after interventions. Comparisons were performed between before and after intervention in nerve block group and sham group. The results indicated that compared with sham group, the subjects in nerve block group had significant reduction with pain score, pain duration, and other analgesic medications, as well as improvement of quality of life (P < 0.05, respectively). In conclusion, nerve block is an effective method for treating patients with end-stage pancreatic cancerous pain.

Keywords

Nerve block Pancreatic cancerous pain Clinical trial 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

The present study was supported by the Post-Graduate Scientific Research Innovation Project of Education Department of Jiangsu Province (CXZZ12_0842), China; the open fund of the Stem Cell and Biomedical Material Key Laboratory of Jiangsu Province (KJS1230), China; Science and Technology Research Project of Science, and Technology Bureau of Suzhou City (SYS201330), China.

Conflicts of interest

None

References

  1. 1.
    Papadopoulos D, Kostopanagiotou G, Batistaki C. Bilateral thoracic splanchnic nerve radiofrequency thermocoagulation for the management of end-stage pancreatic abdominal cancer pain. Pain Physician. 2013;16(2):125–33.PubMedGoogle Scholar
  2. 2.
    Tschoep-Lechner KE, Milani V, Berger F, Dieterle N, Abdel-Rahman S, Salat C, et al. Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer. Int J Hyperthermia. 2013;29(1):8–16.PubMedCrossRefGoogle Scholar
  3. 3.
    Rong Y, Wu W, Ni X, Kuang T, Jin D, Wang D, et al. Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumor Biol. 2013;34(3):1523–30.CrossRefGoogle Scholar
  4. 4.
    Mercadante S, Craig D, Giarratano A. US Food and Drug Administration's Risk Evaluation and Mitigation Strategy for extended-release and long-acting opioids: pros and cons, and a European perspective. Drugs. 2012;72(18):2327–32.PubMedCrossRefGoogle Scholar
  5. 5.
    Glaser SE, Goodman IJ, Broadnax JP. Concerns voiced over methadone results. Pain Physician. 2011;14(2):247–9.Google Scholar
  6. 6.
    Park BB, Yoon JS, Kim ES, Choi J, Won YW, Choi JH, et al. Inhibitory effects of eupatilin on tumor invasion of human gastric cancer MKN-1 cells. Tumor Biol. 2013;34(2):875–85.CrossRefGoogle Scholar
  7. 7.
    Ceelie I, de Wildt SN, van Dijk M, van den Berg MM, van den Bosch GE, Duivenvoorden HJ, et al. Effect of intravenous paracetamol on postoperative morphine requirements in neonates and infants undergoing major noncardiac surgery: a randomized controlled trial. JAMA. 2013;309(2):149–54.PubMedCrossRefGoogle Scholar
  8. 8.
    Bektas M, Atiq M, Bhutani MS. First report of celiac plexus block for refractory abdominal pain secondary to peripancreatic colon cancer metastasis. Gastrointest Endosc. 2012;76(3):692–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Garcea G, Thomasset S, Berry DP, Tordoff S. Percutaneous splanchnic nerve radiofrequency ablation for chronic abdominal pain. ANZ J Surg. 2005;75(8):640–4.PubMedCrossRefGoogle Scholar
  10. 10.
    Wang X, Deng Y, Mao Z, Ma X, Fan X, Cui L, et al. CCN1 promotes tumorigenicity through Rac1/Akt/NF-kB signaling pathway in pancreatic cancer. Tumor Biol. 2012;33(5):1745–58.CrossRefGoogle Scholar
  11. 11.
    Loukas M, Klaassen Z, Merbs W, Tubbs RS, Gielecki J, Zurada A. A review of the thoracic splanchnic nerves and celiac ganglia. Clin Anat. 2010;23(5):512–22.PubMedCrossRefGoogle Scholar
  12. 12.
    Johnson CD, Berry DP, Harris P, Pickering RM, Davis C, George S, et al. An open randomized comparison of clinical effectiveness of protocol-driven opioid analgesia, celiac plexus block or thoracoscopic splanchnicectomy for pain management in patients with pancreatic and other abdominal malignancies. Pancreatology. 2009;9(6):755–63.PubMedCrossRefGoogle Scholar
  13. 13.
    Yarmohammadi H, Nakamoto DA, Azar N, Hayek SM, Haaga JR. Percutaneous computed tomography guided cryoablation of the celiac plexus as an alternative treatment for intractable pain caused by pancreatic cancer. J Cancer Res Ther. 2011;7(4):481–3.PubMedCrossRefGoogle Scholar
  14. 14.
    Aprile G, Avellini C, Reni M, Mazzer M, Foltran L, Rossi D, et al. Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma. Tumor Biol. 2013;34(1):131–7.CrossRefGoogle Scholar
  15. 15.
    Xue YZ, Sheng YY, Liu ZL, Wei ZQ, Can HY, Wu YM, et al. Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance. Tumor Biol. 2013;34(2):895–9.CrossRefGoogle Scholar
  16. 16.
    Levy MJ, Chari ST, Wiersema MJ. Endoscopic ultrasound-guided celiac neurolysis. Gastrointest Endosc Clin N Am. 2012;22(2):231–47.PubMedCrossRefGoogle Scholar
  17. 17.
    Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev. 2011;16(3):CD007519. doi: 10.1002/14651858.CD007519.pub2.
  18. 18.
    Liu TC, Hamitton N, Hawkins W, Gao F, Cao D. Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol. 2013;37(6):853–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Lootens CC, Rapoff MA. Measures of pediatric pain. 21-numbered circle Visual Analog Scale (VAS), E-Ouch Electronic Pain Diary, Oucher, Pain Behavior Observation Method, Pediatric Pain Assessment Tool (PPAT), and Pediatric Pain Questionnaire (PPQ). Arthritis Care Res. 2011;63(S11):253–62.CrossRefGoogle Scholar
  20. 20.
    Gimeno-García AZ, Elwassief A, Paguin SC, Sahai AV. Fatal complication after endoscopic ultrasound-guided celiac plexus neurolysis. Endoscopy. 2012;44(S2):267–76.Google Scholar
  21. 21.
    Djan R, Penington A. A systematic review of questionnaires to measure the impact of appearance on quality of life for head and neck cancer patients. J Plast Reconstr Aesthet Surg. 2013;66(5):647–59.PubMedCrossRefGoogle Scholar
  22. 22.
    Andersson J, Angenete E, Gellerstedt M, Angeras U, Jess P, Rosenberg J, et al. Health-related quality of life after laparoscopic and open surgery for rectal cancer in a randomized trial. Br J Surg. 2013;100(7):941–9.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Maruyama R, Suzuki H, Yamamoto E, Imai K, Shinomura Y. Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer. Tumor Biol. 2012;33(2):277–85.CrossRefGoogle Scholar
  24. 24.
    Bahn BM, Erdek MA. Celiac plexus block and neurolysis for pancreatic cancer. Curr Pain Headache Rep. 2013;17(2):310.PubMedCrossRefGoogle Scholar
  25. 25.
    Hilgier M, Rykowski JJ. One needle transcrural celiac plexus block. Single shot or continuous technique, or both. Reg Anesth. 1994;19(4):277–83.PubMedGoogle Scholar
  26. 26.
    Rykowski JJ, Hilgier M. Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: influence on pain relief. Anesthesiology. 2000;92(2):347–54.PubMedCrossRefGoogle Scholar
  27. 27.
    David Prologo J, Snyder LL, Cherullo E, Passalacgua M, Pirasteh A, Corn D. Percutaneous CT-guided cryoablation of the dorsal penile nerve for treatment of symptomatic premature ejaculation. J Vasc Interv Radiol. 2013;24(2):214–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Kurup AN, Woodrum DA, Morris JM, Atwell TD, Schmit GD, Welch TJ, et al. Cryoablation of recurrent sacrococcygeal tumors. J Vasc Interv Radiol. 2012;23:1070–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Wang DS, Zhang DS, Qiu MZ, Wang ZQ, Luo HY, Wang FW, et al. Prognostic factors and survival in patients with neuroendocrine tumors of the pancreas. Tumor Biol. 2011;32(4):697–705.CrossRefGoogle Scholar
  30. 30.
    Thakkar A, Sutaria D, Grandhi BK, Wang J, Prabhu S. The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer. Oncol Rep. 2013;29(4):1671–7.PubMedCentralPubMedGoogle Scholar
  31. 31.
    Li J, Chen X, Yang H, Wang X, Yuan D, Zeng Y, et al. Tumour cryoablation combined with palliative bypass surgery in the treatment of unresectable pancreatic cancer: a retrospective study of 142 patients. Postgrad Med J. 2011;87(1024):89–95.PubMedCrossRefGoogle Scholar
  32. 32.
    Ilfeld BM. Continuous peripheral nerve blocks: a review of the published evidence. Anesth Analg. 2011;113(4):904–25.PubMedGoogle Scholar
  33. 33.
    Aguirre J, Del Moral A, Cobo I, Borgeat A, Blumenthal S. The role of continuous peripheral nerve blocks. Anesthesiol Res Pract. 2012;2012:560879.PubMedCentralPubMedGoogle Scholar
  34. 34.
    Iwata K, Yasuda I, Enya M, Mukai T, Nakashima M, Doi S, et al. Predictive factors for pain relief after endoscopic ultrasound-guided celiac plexus neurolysis. Dig Endosc. 2011;23(2):140–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Spinks T, Albright HW, Feeley TW, Walters R, Burke TW, Aloia T, et al. Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America. Cancer. 2012;118(10):2571–82.PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    Basiński A, Stefaniak T, Stadnyk M, Sheikh A, Vingerhoets AJ. Influence of religiosity on the quality of life and on pain intensity in chronic pancreatitis patients after neurolytic celiac plexus block: case-controlled study. Relig Health. 2013;52(1):276–84.CrossRefGoogle Scholar
  37. 37.
    Cui L, Deng Y, Rong Y, Lou W, Mao Z, Feng Y, et al. IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumor Biol. 2012;33(1):247–55.CrossRefGoogle Scholar
  38. 38.
    Stefaniak T, Basinski A, Vingerhoets A, Makarewicz W, Connor S, Kaska L, et al. A comparison of two invasive techniques in the management of intractable pain due to inoperable pancreatic cancer: neurolytic celiac plexus block and videothoracoscopic splanchnicectomy. Eur J Surg Oncol. 2005;31(7):768–73.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  • Ling Gao
    • 1
  • Yi-jin Yang
    • 2
  • Hai-yan Xu
    • 2
  • Jin Zhou
    • 1
  • Han Hong
    • 3
  • Yun-liang Wang
    • 1
  • De-chun Li
    • 1
  1. 1.Department of General SurgeryThe First Affiliated Hospital of Soochow UniversitySuzhouChina
  2. 2.Department of Oncology, Suzhou Kowloon HospitalShanghai Jiaotong University School of MedicineSuzhouChina
  3. 3.Department of General SurgeryThe East District of Suzhou Municipal HospitalSuzhouChina

Personalised recommendations